Patient experience in clinical trials: results of a survey
Heart failure patients have benefited from many advances in medication, devices, and changes to the organization of care.
1,2 Clinical trials require a huge investment of resources.
Developing new medicines takes at least 10 years from drug discovery to availability at an estimated cost of £1.15 billion per drug. 3 Despite the careful selection of participating centres, many clinical trials fail to recruit their original target sample size within the recruitment window leading to increased costs and time delays, or studies being underpowered. Health care professionals identify restrictive eligibility criteria, ineffective methods for finding suitable patients, complex information sheets, and burdensome protocols as barriers to recruitment in clinical trials. 4 In the UK the National Institute of Health Research (NIHR) and hospital trusts have worked hard to improve the accessibility of research studies to patients, which has led to a large increase in the number of patients taking part over the past 5 years. 5 Efficient recruitment, retention, and possible re-entry of patients into further research trials remain an important priority for sponsors and health care organizations.
We explored the patients' experiences of taking part in a research trial to see if we could Group 1-intensive studies. The following studies were more invasive or intensive in design and required patients to be followed up in person.
• SERVE-HF: a long-term international, multicentre randomized controlled trial (RCT) designed to assess the effects of adaptive servo-ventilation on morbidity and mortality in patients with central sleep apnoea and heart failure with reduced ejection fraction (NCT00733343).
• INOVATE-HF: a long-term international, multicentre RCT designed to evaluate vagal nerve stimulation in patients with chronic heart failure (NCT01303718).
• ERICCA: a randomized 12-month UK study assessing whether remote ischaemic pre-conditioning can improve outcomes in higher surgical risk patients undergoing coronary artery bypass graft (NCT01247545).
Group 2-remote monitoring studies.
The following studies were non-invasive and used remote equipment to monitor patients. All follow-up was carried out by telephone or post.
• Sleep Minder: a 24-month study looking at the use of a non-contact screening device (SleepMinder™) to diagnose sleep-disordered breathing in heart failure patients.
• REM-HF: a long-term RCT designed to assess the clinical and cost-effectiveness of weekly remote monitoring in heart failure patients with implantable cardiac devices (ISRCTN96536028).
uncover ways of improving their experience and aid future recruitment and retention in research studies.
Patients enrolled into one of five heart failure research studies (Box 1) were asked to complete a questionnaire about their experience of taking part. The questions followed the research journey and focused on three key stages: recruitment, study follow-up, and their attitude to taking part in future research. To maximize our response rate, we included a stamped addressed envelope. The questionnaire was completed at the end of the patient's involvement in the parent study.
Between January 2013 and December 2015, 266 patients were sent questionnaires. One hundred and eighty-six patients (70%) returned completed questionnaires. The mean age was 74 years (age range 45-92). One hundred and sixty-seven patients (84%) were male. We split the results by study intensity to see if there were any differences (Box 1).
Recruitment: 166 patients (93%) were satisfied with the setting in which they were approached to take part in the study and thought they were given sufficient privacy and time to ask questions. The written patient information sheet was easy to understand for 149 (91%) and 124 (76%) were satisfied with the amount of information it contained ( Table 1) .
Study follow-up: during the study followup 150 patients (97%) were satisfied with the accessibility of the research team. Similarly, 137 (88%) were satisfied with the organization of their follow-up and 138 (79%) were satisfied with their level of involvement in clinical decision-making. Seventy-two patients (89%) in the intensive study group felt well informed about the study progress whilst 41 (43%) of the remote monitoring group felt well informed ( Table 1) .
Future research: a higher percentage of patients in the remote monitoring group (87% vs. 58%) were interested in hearing about future research and 85% of patients in the remote monitoring group were likely to participate again in comparison with 47% of the intensive study group ( Table 1) .
Our study shows that patients recruited into clinical trials have high levels of satisfaction with the way in which they are initially recruited, the information they receive, and the time they have to decide on their participation. A greater percentage of patients in the intensive study group felt well informed of the study progress. We did not explore the reasons for this but it may result from less face-to-face contact in the remote monitoring group and a shorter follow-up period providing less time for dialogue and questions. Being less informed of study progress did not appear to stop patients wanting to take part in future research. The intensive study group, despite reporting positive experiences throughout the study, were less likely to take part in future research than the remote monitoring study. This could be due to the invasive procedures or more intense protocol and may be worth further exploration. Number (percentages) are for those who answered the specific questions (n in column 1).
Our findings suggest that strategies to increase patient recruitment and re-entry into clinical trials should include ensuring good communication continues throughout follow-up and that patients are included in the dissemination of study progress and findings. In practice this can be difficult as study results are available some time after the study conclusion. One way of improving dissemination and accessibility of study findings could be to use social media and web pages to update participants; these can be accessed by patients and carers as and when they wish and would not require the patient to maintain communication links with the hospital setting in the years between study closure and results being available. Websites could also update participating patients of news throughout the study period. They may also provide a platform for patients to get in contact with each other. Informing patients at all stages of a research study, without weakening the study integrity by unblinding, is important and may help patients feel valued and meaningfully involved. 6 Involving patients in research ideas, protocol design, and writing information sheets has the potential to make studies more appealing to patients and aid recruitment. In the UK this has led to the set-up of many patient and public involvement groups. Our results suggest this has been successful in ensuring patient-centred approaches during the start of the study, but point to the need for greater emphasis on continuing to involve patients as the trials progress.
In conclusion, we have shown that overall satisfaction of taking part in research was high. Patients with a more intense followup schedule felt better informed about study progress than patients in the remote monitoring studies. The design and protocol of the study may have an impact on a patient's willingness to take part in future research. The focus on improving recruitment into clinical trials and ensuring clear information for informed consent needs to be extended towards ensuring good communication throughout follow-up and involving patients in dissemination of study findings, which could be achieved through
